Cipla, a leading drug maker, witnessed a fall in share price on Friday after it announced a drop in consolidated net profit for the quarter ended September 2014. During the quarter, the profit of the company declined 16.58% to Rs 2,986.80 million from Rs 3,580.60 million in the same quarter last year.

Net sales for the quarter rose 9.27% to Rs 27,672.90 million, compared with Rs 25,325 million for the prior year period.

Shares of the company are trading at Rs 611.60, down Rs 12.55, or 2.01% at the Bombay Stock Exchange (BSE) on Friday at 10:24 a.m.

The scrip has touched an intra-day high of Rs 629.00 and low of Rs 610.00. The total volume of shares traded at the BSE is 143,375.